Trial of the Week: CHAMPION PHOENIX

Pharmacy to Dose: The Critical Care Podcast

内容由Nick Peters提供。所有播客内容（包括剧集、图形和播客描述）均由 Nick Peters 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

1M ago 1:00:35

MP3•单集首页

Trial of the Week: CHAMPION PHOENIX

Special Guest: Jack Pluenneke, PharmD, BCCP @JackPluenneke

Jack Pluenneke joins to discuss a March 2024 Trial of the Week, “Effect of platelet inhibition with cangrelor during PCI on ischemic events” the CHAMPION PHOENIX trial, published in 2013 in NEJM.

We review PK/PD advantages with cangrelor, go over the CHAMPION trials, and then highlight why the CHAMPION PHOENIX trial was necessary. Then we dive into the Trial of the Week: CHAMPION PHOENIX trial and discuss its findings as well as study design. Are these patients we’d see in our ICU? How does cangrelor compare to glycoprotein 2b/3a inhibitors? Is it a weakness that the comparator group uses clopidogrel? The episode closes with medication safety considerations, cangrelor’s place in therapy, and much more.

Reference list: https://pharmacytodose.files.wordpress.com/2024/03/champion-phoenix-trial-of-the-week-references-1.pdf

PharmacyToDose.Com

@PharmacyToDose

PharmacyToDose@Gmail.com

Learn more about your ad choices. Visit megaphone.fm/adchoices

148集单集

#Fitness #Nick Peters #Medicine #Science #Special Guests #Pharmacy